Atlas Trials

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Clinical trial NCT00588666 · COMPLETED

Trial details

NCT number
NCT00588666
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myeloproliferative DisorderUrothelial CarcinomaCancer
Start date
2006-05-01
Primary completion
2011-12-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.